Skip Nav Destination
Close
Article navigation
February 1976
This article was originally published in
Clinical Science and Molecular Medicine
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Conference Abstract|
February 01 1976
Anti-Hypertensive Effect of Propranolol and Spironolactone in Relation to Plasma Angiotensin II
G. A. MacGregor
;
G. A. MacGregor
1Department of Medicine, New Charing Cross Hospital, London, and Department of Pharmacology, I.C.I., Macclesfield
Search for other works by this author on:
P. Dawes
P. Dawes
1Department of Medicine, New Charing Cross Hospital, London, and Department of Pharmacology, I.C.I., Macclesfield
Search for other works by this author on:
Clin Sci Mol Med (1976) 50 (2): 18P.
Citation
G. A. MacGregor, P. Dawes; Anti-Hypertensive Effect of Propranolol and Spironolactone in Relation to Plasma Angiotensin II. Clin Sci Mol Med 1 February 1976; 50 (2): 18P. doi: https://doi.org/10.1042/cs050018P
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
2
Views
0
Citations
Cited By
Related Articles
Effect of Spironolactone on Aldosterone Regulation in Man
Clin Sci (Lond) (March,1980)
Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress
Biosci Rep (July,2016)
Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus
Clin Sci (Lond) (July,2015)
Aldosterone antagonists destabilize the mineralocorticosteroid receptor
Biochem J (March,1992)